New scan aims to spot hidden kidney cancers without surgery

NCT ID NCT06949215

Recruiting now Diagnosis Sponsor: Peking Union Medical College Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special PET/CT scan using a radioactive tracer called 68Ga-NYM096 to see if it can accurately detect clear cell kidney cancer in people with complex kidney cysts who are scheduled for surgery. About 70 participants will receive the tracer and undergo imaging before their operation. The results will be compared to the final tissue diagnosis to measure the scan's accuracy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 68Ga-NYM096 (a radioactive tracer for PET/CT imaging)
What this could lead to: If successful, this could provide a non-invasive way to accurately detect clear cell kidney cancer in complex cysts, helping guide surgery decisions.
What could go wrong: This is an early phase 2 study with only 70 participants at one hospital. The scan may not be accurate enough to replace standard biopsy or could miss some cancers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CCRCC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

clear cell renal carcinoma nonpapillary renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CCRCC COMPLEX RENAL CYST

Contacts and locations

Locations

Peking Union Medical College
RECRUITING

Beijing, 100730, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.